glp-1 gip therapy alternatives 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Comparing GLP‑1 Drugs With Other
Description
GLUCAGON-LIKE PEPTIDE-1 GLP-1 is a peptide hormone secreted by intestinal enteroendocrine L-cells, specific neurons of the solitary tract in the brainstem and some -cells in the pancreas [28]
R.WefersJ.MeierJ
EMA, European medicines agency
The review also explored emerging innovations such as ultralong-acting formulations, combination therapies, and the integration of digital health and artificial intelligence in advancing antiobesity drug development
One retrospective study analyzed the association of semaglutide and tirzepatide use with weight loss in patients with early breast cancer (stage IIII)
cmh-2022-0330-Supplementary-5.pdf Supplementary Material 6
